Pure Global Cannabis Inc. Announces Strategic Supply Agreements with Three ACMPR Licensed Producers

Published: July 27, 2018

Pure Global Cannabis Inc. Announces Strategic Supply Agreements with Three ACMPR Licensed Producers

Pure Global Cannabis Inc. announced that its wholly-owned subsidiary, PureSinse Inc. has signed definitive Supply Agreements with The Supreme Cannabis Company, Inc. and two other reputable Access to Cannabis for Medical Purposes Regulations (“ACMPR”) Licensed Producers, from whom PureSinse has purchased various quantities of premium quality medical cannabis that meet the high-quality standard requirements of PURE.

These Agreements represent a significant milestone for PureSinse, as it has now received the necessary product required to obtain a Sales License under the ACMPR which is expected in Q3 2018.

Pure Global President & CEO Malay Panchal stated, “Procuring adequate supply of quality cannabis is an important milestone for PURE as we approach our full market launch for serving medical cannabis patients across Canada within the next several months.” “We will continue to work with Supreme and several other premium quality ACMPR producers to execute Phase I of our business model to initiate revenue generation as soon as possible,” Panchal added.